TJC’s new Maternal Complication Standards

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jgold@ismp.org. 

1 post / 0 new
Log in or register to post comments
Tue, 10/01/2019 - 12:56
#1
Kelly Besco
Kelly Besco's picture
Offline
Last seen: 4 years 1 week ago
Joined: 06/24/2014 - 15:43
TJC’s new Maternal Complication Standards

I hope this post finds you well. Our hospitals have been working on developing processes/strategies to align with TJC’s new Maternal Complication Standards.

One of the projects involves emergent management of eclampsia. The protocol that our OBs are proposing is from ACOG and recommends that 5 gm/5 mL intraMUSCULAR magnesium (x2 doses) be given to patient that do NOT have IV access. The total dose equates to 10 grams and involves using 50 % concentrated magnesium.

Our OBs are asking for the magnesium to be available in Pyxis for emergent use. This would deviate from our current standard of limiting concentrated electrolytes to Pharmacy storage only.

I'm interested in how others are managing this at their site. Best, KB

Top